Evidence map›Paper›PMID 38126623›Full record

ArticleJournal of clinical hypertension (Greenwich, Conn.)2024

Management of nocturnal hypertension: An expert consensus document from Chinese Hypertension League.

Jing Liu, Yan Li, Xinjun Zhang, Peili Bu, Xueping Du, Lizheng Fang, Yingqing Feng, Yifang Guo, Fei Han, Yinong Jiang and 18 more

Open access · diamondAbstract readConsensus Statement
In one paragraph

Article in Journal of clinical hypertension (Greenwich, Conn.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 3 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 3 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Review
  8. Asian expert consensus on high-quality hypertension management.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Does the timing of blood pressure medication really matter?International journal of cardiology. Cardiovascular risk and prevention · 2024
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 20 institutions in 1 country.

Jing LiuPeking University People's Hospital, Beijing, China.ORCID 0000-0002-9714-7708
Yan LiRuijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.ORCID 0000-0002-5825-5968
Xinjun ZhangWest China Hospital of Sichuan University, Chengdu, Sichuan, China.
Peili BuQilu Hospital of Shandong University, Jinan, Shandong, China.
Xueping DuYuetan Community Health Service Center, Fuxing Hospital, Capital Medical University, Beijing, China.
Lizheng FangSir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Yingqing FengGuangdong Provincial People's Hospital, Guangzhou, Guangdong, China.
Yifang GuoHebei General Hospital, Shijiazhuang, Hebei, China.
Fei HanThe First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Yinong JiangThe First Affiliated Hospital of Dalian Medical University, Dalian, China.
Yuming LiT International Cardiovascular Hospital, Tianjin, China.
Jinxiu LinThe First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.
Min LiuHenan Province People's Hospital, Zhengzhou, Henan, China.
Wei LiuBeijing Hospital, Beijing, China.
Mingzhi LongThe Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Jianjun MuThe First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.ORCID 0000-0002-0335-3528
Ningling SunPeking University People's Hospital, Beijing, China.ORCID 0000-0003-0378-2813
Hao WuSchool of General Practice and Continuing Education, Capital Medical University, Beijing, China.
Jianhong XieZhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China.ORCID 0000-0002-0447-8496
Jingyuan XieRuijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Liangdi XieThe First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.ORCID 0000-0001-5544-3149
Jing YuLanzhou University Second Hospital, Lanzhou, Gansu, China.
Hong YuanThe Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
Yan ZhaGuizhou Provincial People's Hospital, Guiyang, Guizhou, China.
Yuqing ZhangFuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.ORCID 0000-0001-8142-8305
Shanzhu ZhuZhongshan Hospital, Fudan University, Shanghai, China.
Jiguang WangRuijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Chinese Hypertension League expert consensus committee on the management of nocturnal hypertension
Ruijin Hospital · CNCapital Medical University · CNFujian Medical University · CNPeking University · CNTEDA International Cardiovascular Hospital · CNBeijing Hospital · CNCentral South University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNDalian Medical University · CNFirst Affiliated Hospital of Xi'an Jiaotong University · CNFirst Affiliated Hospital Zhejiang University · CNGuangdong Provincial People's Hospital · CNGuizhou Provincial People's Hospital · CNHebei General Hospital · CNHenan Provincial People's Hospital · CNLanzhou University Second Hospital · CNQilu Hospital of Shandong University · CNSecond Affiliated Hospital of Nanjing Medical University · CNSichuan University · CNSir Run Run Shaw Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nocturnal hypertension is highly prevalent among Chinese and Asian populations, which is mainly attributed to high salt intake and high salt sensitivity. Nocturnal hypertension increases the risk of cardiovascular and all-cause mortality, independent of daytime blood pressure (BP). However, it can usually be detected by 24-h ambulatory BP monitoring, rather than routine office or home BP measurement, thus is often underdiagnosed in clinical practice. Currently, no specific guidance is available for the management of nocturnal hypertension in China or worldwide. Experts from the Chinese Hypertension League summarized the epidemiologic and pathophysiologic characteristics and clinical phenotype of nocturnal hypertension and provided consensus recommendations on optimal management of nocturnal hypertension, with the goal of maximally reducing the cardiovascular disease risks. In this consensus document, 24-h ABPM is recommended for screening and diagnosis of nocturnal hypertension, especially in the elderly, patients with diabetes, chronic kidney diseases, obstructive sleep apnea and other conditions prone to high nocturnal BP. Lifestyle modifications including salt intake restriction, exercise, weight loss, sleep improvement, and mental stress relief are recommended. Long-acting antihypertensive medications are preferred for nocturnal and 24-h BP control. Some newly developed agents, renal denervation, and other device-based therapy on nocturnal BP reduction are evaluated.

Indexed as

HypertensionAgedAntihypertensive AgentsBlood PressureBlood Pressure Monitoring, AmbulatoryCircadian RhythmConsensusHumansSodium Chloride, DietaryAntihypertensive AgentsSodium Chloride, Dietaryclinical managementexpert consensusnocturnal hypertension

Identifiers

PMID38126623
PMCPMC10795100
OpenAlexW4390052041

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.